Curaleaf Holdings (CURLF) Beginning Cash Balance (2020 - 2022)
Curaleaf Holdings (CURLF) posted quarterly Beginning Cash Balance of $299.3 million for Q1 2022, up 307.02% year-on-year from $73.5 million in Q1 2021, and up 307.02% on a QoQ basis from $73.5 million in Q1 2021.
Curaleaf Holdings (CURLF) Beginning Cash Balance (2020 - 2022) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Beginning Cash Balance for 3 consecutive years, with $299.3 million the latest figure, recorded in Q1 2022.
- Quarterly Beginning Cash Balance rose 307.02% year-over-year to $299.3 million in Q1 2022, while the trailing twelve-month figure through Sep 2022 was $299.3 million (up 307.02% YoY) and the FY2021 annual result came in at $73.5 million, up 73.82% from the prior year.
- Beginning Cash Balance advanced to $299.3 million in Q1 2022 per CURLF's latest filing, from $73.5 million in the prior quarter.
- Over the last five years, Beginning Cash Balance for CURLF reached as high as $299.3 million in Q1 2022 and fell as low as $42.3 million in Q1 2020.
- A 3-year average of $138.4 million and a median of $73.5 million in 2021 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2021 — Beginning Cash Balance surged 73.82% — and 2022, when it soared 307.02%.
- Year by year, Beginning Cash Balance stood at $42.3 million in 2020, then jumped by 73.82% to $73.5 million in 2021, then surged by 307.02% to $299.3 million in 2022.
- According to Business Quant data, Beginning Cash Balance over the past three periods registered $299.3 million, $73.5 million, and $42.3 million for Q1 2022, Q1 2021, and Q1 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 299.33 Mn |
| Mar 31, 2022 | 299.33 Mn |
| Mar 31, 2021 | 73.54 Mn |
| Mar 31, 2021 | 73.54 Mn |
| Mar 31, 2020 | 42.31 Mn |
| Mar 31, 2020 | 42.31 Mn |